COGT
Price
$37.08
Change
+$1.38 (+3.87%)
Updated
Feb 6 closing price
Capitalization
5.69B
37 days until earnings call
Intraday BUY SELL Signals
KRYS
Price
$272.74
Change
+$5.10 (+1.91%)
Updated
Feb 6 closing price
Capitalization
7.9B
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs KRYS

Header iconCOGT vs KRYS Comparison
Open Charts COGT vs KRYSBanner chart's image
Cogent Biosciences
Price$37.08
Change+$1.38 (+3.87%)
Volume$1.77M
Capitalization5.69B
Krystal Biotech
Price$272.74
Change+$5.10 (+1.91%)
Volume$327.55K
Capitalization7.9B
COGT vs KRYS Comparison Chart in %
View a ticker or compare two or three
VS
COGT vs. KRYS commentary
Feb 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and KRYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 08, 2026
Stock price -- (COGT: $37.08 vs. KRYS: $272.74)
Brand notoriety: COGT and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 74% vs. KRYS: 106%
Market capitalization -- COGT: $5.69B vs. KRYS: $7.9B
COGT [@Biotechnology] is valued at $5.69B. KRYS’s [@Biotechnology] market capitalization is $7.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 5 bearish.
  • KRYS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а +3.26% price change this week, while KRYS (@Biotechnology) price change was -2.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

COGT is expected to report earnings on Mar 17, 2026.

KRYS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($7.9B) has a higher market cap than COGT($5.69B). KRYS YTD gains are higher at: 10.627 vs. COGT (4.392). KRYS has higher annual earnings (EBITDA): 165M vs. COGT (-308.13M). KRYS has more cash in the bank: 731M vs. COGT (391M). KRYS has less debt than COGT: KRYS (9.51M) vs COGT (60.6M). KRYS has higher revenues than COGT: KRYS (373M) vs COGT (0).
COGTKRYSCOGT / KRYS
Capitalization5.69B7.9B72%
EBITDA-308.13M165M-187%
Gain YTD4.39210.62741%
P/E RatioN/A40.89-
Revenue0373M-
Total Cash391M731M53%
Total Debt60.6M9.51M637%
FUNDAMENTALS RATINGS
COGT vs KRYS: Fundamental Ratings
COGT
KRYS
OUTLOOK RATING
1..100
8176
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
2620
SMR RATING
1..100
9946
PRICE GROWTH RATING
1..100
3438
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (50) in the Miscellaneous industry is in the same range as KRYS (50) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (20) in the Pharmaceuticals Major industry is in the same range as COGT (26) in the Miscellaneous industry. This means that KRYS’s stock grew similarly to COGT’s over the last 12 months.

KRYS's SMR Rating (46) in the Pharmaceuticals Major industry is somewhat better than the same rating for COGT (99) in the Miscellaneous industry. This means that KRYS’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Price Growth Rating (34) in the Miscellaneous industry is in the same range as KRYS (38) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to KRYS’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as KRYS (100) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to KRYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTKRYS
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
74%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 18 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signal:
Gain/Loss:
KRYS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBCRX17.490.47
+2.76%
William Blair Small-Mid Cap Core R6
FTQGX40.111.00
+2.56%
Fidelity Focused Stock
RERHX63.131.52
+2.47%
American Funds EUPAC R5E
MBERX32.610.35
+1.08%
NYLI Balanced Class R6
MFWJX18.250.19
+1.05%
MFS Global Total Return R4

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been closely correlated with TERN. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if COGT jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+3.87%
TERN - COGT
80%
Closely correlated
+6.88%
ACET - COGT
79%
Closely correlated
+9.16%
ERAS - COGT
79%
Closely correlated
+3.45%
INBX - COGT
78%
Closely correlated
+2.92%
RVMD - COGT
78%
Closely correlated
+1.39%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been closely correlated with RVMD. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if KRYS jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+1.91%
RVMD - KRYS
73%
Closely correlated
+1.39%
ERAS - KRYS
71%
Closely correlated
+3.45%
VRDN - KRYS
69%
Closely correlated
+0.27%
ATOS - KRYS
69%
Closely correlated
+0.19%
COGT - KRYS
68%
Closely correlated
+3.87%
More